Corrigendum to “Adenoviral Delivery of Tumor Necrosis Factor-α and Interleukin-2 Enables Successful Adoptive Cell Therapy of Immunosuppressive Melanoma”

Corrigendum to “Adenoviral Delivery of Tumor Necrosis Factor-α and Interleukin-2 Enables Successful Adoptive Cell Therapy of Immunosuppressive Melanoma” Molecular Therapy 24, 2033 (November 2016). doi:10.1038/mt.2016.196
Source: Molecular Therapy - Category: Genetics & Stem Cells Source Type: research